|
1
|
Jemal A, Center MM, DeSantis C and Ward
EM: Global patterns of cancer incidence and mortality rates and
trends. Cancer Epidemiol Biomarkers Prev. 19:1893–1907. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Khuhaprema T and Srivatanakul P: Colon and
rectum cancer in Thailand: An overview. Jpn J Clin Oncol.
38:237–243. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Khuhaprema T, Attasara P, Sriplung H,
Wiangnon S and Sangrajrang S: Cancer in Thailand. 7:Bangkok,
Thailand: National Cancer Institute. 2007–2009. 2013.
|
|
4
|
Sriplung H, Bilheem S, Kuntipundee T and
Geater SL: Differences in cancer incidence among predominantly
Muslim and Buddhist subpopulations in Songkhla. Asian Pac J Cancer
Prev. 15:9979–9983. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kritsanasakul A, Boonpipattanapong T,
Wanitsuwan W, Phukaoloun M, Prechawittayakul P and Sangkhathat S:
Impact of lymph node retrieval on surgical outcomes in colorectal
cancers. J Surg Oncol. 106:238–242. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Boonpipattanapong T and Chewatanakornkul
S: Preoperative carcinoembryonic antigen and albumin in predicting
survival in patients with colon and rectal carcinomas. J Clin
Gastroenterol. 40:592–595. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu Z, Zhang Y, Niu Y, Li K, Liu X, Chen H
and Gao C: A systematic review and meta-analysis of diagnostic and
prognostic serum biomarkers of colorectal cancer. PLoS One.
9:e1039102014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Coppedè F, Lopomo A, Spisni R and Migliore
L: Genetic and epigenetic biomarkers for diagnosis, prognosis and
treatment of colorectal cancer. World J Gastroenterol. 20:943–956.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Belov L, Zhou J and Christopherson RI:
Cell surface markers in colorectal cancer prognosis. Int J Mol Sci.
12:78–113. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chaiyapan W, Duangpakdee P,
Boonpipattanapong T, Kanngern S and Sangkhathat S: Somatic
mutations of K-ras and BRAF in Thai colorectal cancer and their
prognostic value. Asian Pac J Cancer Prev. 14:329–332. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bejrananda T, Phukaoloun M,
Boonpipattanapong T, Wanitsuwan W, Kanngern S, Sangthong R and
Sangkhathat S: WT1 expression as an independent marker of poor
prognosis in colorectal cancers. Cancer Biomark. 8:35–42.
2010.2011-2011. PubMed/NCBI
|
|
12
|
Cheever MA, Allison JP, Ferris AS, Finn
OJ, Hastings BM, Hecht TT, Mellman I, Prindiville SA, Viner JL,
Weiner LM, et al: The prioritization of cancer antigens: A National
Cancer Institute pilot project for the acceleration of
translational research. Clin Cancer Res. 15:5323–5337. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu SY, Gu WY, Chen ZX, Wang XL, Cen JN, He
HL, Chai YH and Chen CS: The significance of detecting WT1
expression in childhood acute leukemias. Pediatr Hematol Oncol.
27:581–591. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Oji Y, Miyoshi S, Maeda H, Hayashi S,
Tamaki H, Nakatsuka S, Yao M, Takahashi E, Nakano Y, Hirabayashi H,
et al: Overexpression of the Wilms' tumor gene WT1 in de novo lung
cancers. Int J Cancer. 100:297–303. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Domfeh AB, Carley AL, Striebel JM,
Karabakhtsian RG, Florea AV, McManus K, Beriwal S and Bhargava R:
WT1 immunoreactivity in breast carcinoma: Selective expression in
pure and mixed mucinous subtypes. Mod Pathol. 21:1217–1223. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Oji Y, Yamamoto H, Nomura M, Nakano Y,
Ikeba A, Nakatsuka S, Abeno S, Kiyotoh E, Jomgeow T, Sekimoto M, et
al: Overexpression of the Wilms' tumor gene WT1 in colorectal
adenocarcinoma. Cancer Sci. 94:712–717. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oka Y and Sugiyama H: WT1 peptide vaccine,
one of the most promising cancer vaccines: Its present status and
the future prospects. Immunotherapy. 2:591–594. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Damm F, Heuser M, Morgan M, Yun H,
Grosshennig A, Göhring G, Schlegelberger B, Döhner K, Ottmann O,
Lübbert M, et al: Single nucleotide polymorphism in the mutational
hotspot of WT1 predicts a favorable outcome in patients with
cytogenetically normal acute myeloid leukemia. J Clin Oncol.
28:578–585. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Becker H, Maharry K, Radmacher MD, Mrózek
K, Metzeler KH, Whitman SP, Schwind S, Kohlschmidt J, Wu YZ, Powell
BL, et al: Clinical outcome and gene- and microRNA-expression
profiling according to the Wilms tumor 1 (WT1) single nucleotide
polymorphism rs16754 in adult de novo cytogenetically normal acute
myeloid leukemia: A Cancer and Leukemia Group B study.
Haematologica. 96:1488–1495. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen X, Yang Y, Huang Y, Tan J, Chen Y,
Yang J, Dou H, Zou L, Yu J and Bao L: WT1 mutations and single
nucleotide polymorphism rs16754 analysis of patients with pediatric
acute myeloid leukemia in a Chinese population. Leuk Lymphoma.
53:2195–2204. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chalieopanyarwong V, Boonpipattanapong T,
Prechawittayakul P and Sangkhathat S: Endoscopic obstruction is
associated with higher risk of acute events requiring emergency
operation in colorectal cancer patients. World J Emerg Surg.
8:342013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Compton CC and Greene FL: The staging of
colorectal cancer: 2004 and beyond. CA Cancer J Clin. 54:295–308.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Phusantisampan T, Sangkhathat S, Phongdara
A, Chiengkriwate P, Patrapinyokul S and Mahasirimongkol S:
Association of genetic polymorphisms in the RET-protooncogene and
NRG1 with Hirschsprung disease in Thai patients. J Hum Genet.
57:286–293. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sangkhathat S, Kanngurn S, Chaiyapan W,
Gridist P and Maneechay W: Wilms' tumor 1 gene (WT1) is
overexpressed and provides an oncogenic function in pediatric
nephroblastomas harboring the wild-type WT1. Oncol Lett. 1:615–619.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Abecasis GR, Altshuler D, Auton A, Brooks
LD, Durbin RM, Gibbs RA, Hurles ME and McVean GA: 1000 Genomes
Project Consortium: A map of human genome variation from
population-scale sequencing. Nature. 467:1061–1073. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Altshuler DM, Gibbs RA, Peltonen L, et al:
International HapMap 3 Consortium: Integrating common and rare
genetic variation in diverse human populations. Nature. 467:52–58.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lauhakirti D, Sritana N, Boonthimat C,
Promsuwicha O and Auewarakul CU: WT1 mutations and polymorphisms in
Southeast Asian acute myeloid leukemia. Exp Mol Pathol. 91:682–686.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ho PA, Alonzo TA, Gerbing RB, Kuhn J,
Pollard JA, Hirsch B, Raimondi SC, Gamis AS and Meshinchi S: The
prognostic effect of high diagnostic WT1 gene expression in
pediatric AML depends on WT1 SNP rs16754 status: Report from the
Children's Oncology Group. Pediatr Blood Cancer. 61:81–88. 2014.
View Article : Google Scholar : PubMed/NCBI
|
